While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Hannah's doctor prescribed Saxenda - part of a group of drugs known ... she's more than willing to keep paying the $80-per-week cost. And it's all because of an unexpected side effect that has ...

The governing board of the State Health Plan is expected to give state treasurer Brad Briner the go-ahead Friday to overhaul ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

He spoke on the chances of getting popular weight loss drugs like Saxenda and Wegovy covered again ... as all were grappling with medical cost inflation outpacing other types of inflation.

Saxenda is another GLP-1 receptor agonist FDA ... approach requires a yearlong commitment expensive membership cost doesn’t include cost of GLP-1 medication health coaches not guaranteed to ...

Ivim Health raises concern over US FDA’s arbitrary critical deadline comes; submits Amicus brief to fighting patient access to GLP-1 medications: Columbus, Ohio Thursday, Februa ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

Novo Nordisk’s Saxenda has been recommended by NICE as a treatment for obesity, ending a 10-year drought in new drug therapies for weight management. The cost-effectiveness agency for England ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...